Contact Us: 1-518-583-0095 
We’re Hiring… Join Our Team!
Stay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia. Learn about new treatment guidelines for bladder cancer, promising results from a novel treatment for prostate cancer, and more.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia. Learn about a new radiopharmaceutical therapy for neuroendocrine tumors, the role of AI in breast cancer diagnosis and treatment, and more.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia. Learn about new therapies in non-small cell lung cancer, personalized medicine approaches for cancer treatment, and more.
Continue readingDr. Paul Oberstein, a pancreatic cancer expert and member of the Academic GI Cancer Consortium (AGICC), discusses new data showing positive results from a Phase 3 pancreatic cancer study of an experimental drug by Revolution Medicines.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia. Learn about nanoparticles enhancing radiation therapy in lung cancer, a new study focusing on ER+/HER2 breast cancer, and more.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia, highlighting patient empowerment in clinical trials and a successful therapy for patients with metastatic breast cancer.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia.
Continue reading
Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC), discusses his diagnosis in 2022 of Stage IV EGFR-positive non-small cell lung cancer in an article published in ASTRO (American Society for Radiation Oncology) News.
Dr. Camidge also explores the cancer patient experience from his unique perspective as a treatment provider, researcher and patient in a Cracking Cancer podcast episode and a video interview with The Patient Story.
Continue reading
We are excited to attend the 2026 ASCO Gastrointestinal Cancers Symposium, held in San Francisco on January 8-10, 2026. Our semi-annual Investigator’s Meeting of the Academic GI Cancer Consortium (AGICC) will be held on Thursday, January 8th, bringing together AGICC researchers to discuss new developments, collaboration opportunities and potential studies for 2026.
Continue reading